Conceptus Inc.  (CPTS) Trade Now »     Rate CPTS  -  Discuss CPTS  -  Add to Watch List        

<font> --GAAP loss per share of ($0.02), non-GAAP diluted EPS of $0.08 </font>

<font> --Cash flow from operations of $8.7 million </font>

<font> --Domestic in-office procedures increase to 62% of domestic sales </font>

<font> Conceptus, Inc. ( CPTS ), developer of the Essure(R) procedure, the first proven non-incisional permanent birth control method available, today reported financial results for the three and six months ended June 30, 2009. </font>